Achaogen Company Profile (NASDAQ:AKAO)

About Achaogen

Achaogen logoAchaogen, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterials to treat multi-drug resistant (MDR) gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant enterobacteriaceae (CRE). Plazomicin is an aminoglycoside designed to overcome clinically relevant aminoglycoside resistance mechanisms. In addition, its research and development pipeline includes two programs that specifically target Pseudomonas aeruginosa or Acinetobacter baumannii infections: a program to discover and develop small molecule inhibitors of LpxC, which is an enzyme essential for the synthesis of the outer membrane of gram-negative bacteria, and a therapeutic antibody program. Its development plan for plazomicin includes over two Phase III clinical trials.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AKAO
  • CUSIP:
Key Metrics:
  • Previous Close: $4.30
  • 50 Day Moving Average: $4.04
  • 200 Day Moving Average: $3.66
  • 52-Week Range: $2.59 - $6.52
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.07
  • P/E Growth: 0.00
  • Market Cap: $114.72M
  • Outstanding Shares: 26,679,000
  • Beta: 0.59
Profitability:
  • Net Margins: -209.23%
  • Return on Equity: -118.45%
  • Return on Assets: -68.85%
Debt:
  • Debt-to-Equity Ratio: 0.66%
  • Current Ratio: 5.19%
  • Quick Ratio: 5.19%
Additional Links:
Companies Related to Achaogen:

Analyst Ratings

Consensus Ratings for Achaogen (NASDAQ:AKAO) (?)
Ratings Breakdown: 2 Hold Ratings, 2 Buy Ratings
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $10.00 (132.56% upside)

Analysts' Ratings History for Achaogen (NASDAQ:AKAO)
Show:
DateFirmActionRatingPrice TargetDetails
9/26/2016SunTrust Banks Inc.Reiterated RatingBuyView Rating Details
8/9/2016Needham & Company LLCReiterated RatingHoldView Rating Details
6/14/2016WedbushUpgradeNeutral -> Outperform$7.00 -> $10.00View Rating Details
3/31/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details
8/10/2015Cantor FitzgeraldReiterated RatingBuy$13.00View Rating Details
3/2/2015Credit Suisse Group AGDowngradeOutperform -> Underperform$22.00 -> $13.00View Rating Details
10/30/2014Canaccord GenuityInitiated CoverageBuy$13.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Achaogen (NASDAQ:AKAO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/8/2016Q2($0.67)($0.87)$5.58 million$9.14 millionViewN/AView Earnings Details
3/15/2016Q414($0.58)($0.61)$5.33 million$4.70 millionViewListenView Earnings Details
11/5/2015($0.45)($0.48)ViewN/AView Earnings Details
8/10/2015($0.20)($0.05)ViewN/AView Earnings Details
5/11/2015($0.26)($0.34)ViewN/AView Earnings Details
3/16/2015($0.33)($0.27)ViewN/AView Earnings Details
11/10/2014Q314($0.25)($0.47)$6.00 million$4.52 millionViewN/AView Earnings Details
8/11/2014($0.19)($0.20)ViewN/AView Earnings Details
5/12/2014Q114($0.48)($1.00)$5.39 million$6.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Achaogen (NASDAQ:AKAO)
Current Year EPS Consensus Estimate: $-2.64 EPS
Next Year EPS Consensus Estimate: $-2.08 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20164($0.71)($0.52)($0.62)
Q2 20164($0.71)($0.52)($0.62)
Q3 20163($0.53)($0.33)($0.43)
Q4 20163($0.63)($0.41)($0.48)
Q1 20171($0.56)($0.56)($0.56)
Q2 20171($0.67)($0.67)($0.67)
Q3 20171($0.72)($0.72)($0.72)
Q4 20171($0.67)($0.67)($0.67)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Achaogen (NASDAQ:AKAO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Achaogen (NASDAQ:AKAO)
Insider Ownership Percentage: 13.80%
Institutional Ownership Percentage: 56.84%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/17/2016Ian FriedlandInsiderSell1,772$3.22$5,705.84View SEC Filing  
3/17/2016Kenneth J HillanCEOSell3,572$3.22$11,501.84View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Achaogen (NASDAQ:AKAO)
DateHeadline
finance.yahoo.com logoSunTrust Reiterates Buy On Achaogen, Sees Plazomicin As An 'Undervalued Asset' (NASDAQ:AKAO)
finance.yahoo.com - September 26 at 8:24 PM
investornewswire.com logoShares Of Achaogen, Inc. (NASDAQ:AKAO) Expected To Hit $11 - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - September 25 at 8:10 AM
News IconAchaogen Incorporated (NASDAQ:AKAO) Short Interest Decreased By 9.87% - Frisco Fastball (NASDAQ:AKAO)
friscofastball.com - September 14 at 3:25 PM
kcregister.com logoStocks Swings: Achaogen, Inc. (NASDAQ:AKAO), Hilton Worldwide Holdings Inc. (NYSE:HLT), The TJX Companies ... - KC Register (NASDAQ:AKAO)
www.kcregister.com - September 12 at 3:24 PM
News IconPlacing Achaogen, Inc. (NASDAQ:AKAO) Shares Under the Microscope - Post News (NASDAQ:AKAO)
www.kentuckypostnews.com - September 9 at 8:11 AM
News IconShares Higher in Today's Session: Achaogen, Inc. (NASDAQ:AKAO) - Post News (NASDAQ:AKAO)
www.kentuckypostnews.com - September 8 at 3:23 PM
News IconWhat are Research Firms Saying About Achaogen, Inc. (NASDAQ:AKAO)? - Frisco Fastball (NASDAQ:AKAO)
friscofastball.com - September 7 at 8:32 PM
fxpips.com logoTop 20 Most Advanced Stocks on NASDAQ, Sept. 6 (NASDAQ:AKAO)
www.fxpips.com - September 6 at 8:11 AM
News IconNext Weeks Broker Price Targets For Itron, Inc. (NASDAQ:ITRI) (NASDAQ:AKAO)
magseriesusa.net - September 6 at 8:11 AM
News IconList: Itron, Inc. (NASDAQ:ITRI) , Achaogen, Inc. (NASDAQ:AKAO) (NASDAQ:AKAO)
myhealthbowl.com - September 6 at 8:11 AM
News IconAnalyst Watch-list: Itron, Inc. (NASDAQ:ITRI) , Achaogen, Inc. (NASDAQ:AKAO) - Wall Street Times (press release) (NASDAQ:AKAO)
www.wallstreetnews24.com - September 2 at 3:26 PM
biz.yahoo.com logoACHAOGEN INC Files SEC form 8-K, Other Events (NASDAQ:AKAO)
biz.yahoo.com - September 2 at 8:02 AM
streetinsider.com logoAchaogen (AKAO) Says Phase 3 EPIC Trial Enrollment Complete - StreetInsider.com (NASDAQ:AKAO)
www.streetinsider.com - September 1 at 11:51 AM
finance.yahoo.com logoAchaogen Completes Patient Enrollment in Phase 3 EPIC Clinical Trial of Plazomicin (NASDAQ:AKAO)
finance.yahoo.com - September 1 at 11:51 AM
publicnow.com logoAchaogen Announces New Employment Inducement Grants (NASDAQ:AKAO)
www.publicnow.com - August 22 at 8:12 AM
investornewswire.com logoWill Achaogen, Inc. (NASDAQ:AKAO) Hit $11 Price Target? - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - August 21 at 8:11 AM
biz.yahoo.com logoACHAOGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement (NASDAQ:AKAO)
biz.yahoo.com - August 18 at 8:53 PM
finance.yahoo.com logoACHAOGEN INC Financials (NASDAQ:AKAO)
finance.yahoo.com - August 16 at 3:25 PM
globenewswire.com logoAchaogen to Present at the Wedbush PacGrow Healthcare Conference - GlobeNewswire (press release) (NASDAQ:AKAO)
globenewswire.com - August 10 at 3:45 PM
finance.yahoo.com logoAchaogen to Present at the Wedbush PacGrow Healthcare Conference (NASDAQ:AKAO)
finance.yahoo.com - August 10 at 11:14 AM
globenewswire.com logoAchaogen Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AKAO)
globenewswire.com - August 8 at 8:52 PM
twst.com logoAchaogen Inc.: Achaogen Reports Second Quarter 2016 Financial Results and Provides Corporate Update (NASDAQ:AKAO)
www.twst.com - August 8 at 8:52 PM
sg.finance.yahoo.com logoAchaogen reports 2Q loss (NASDAQ:AKAO)
sg.finance.yahoo.com - August 8 at 8:52 PM
equities.com logoAchaogen Inc. (AKAO) Drops 7.12% on August 01 - Equities.com (NASDAQ:AKAO)
www.equities.com - August 3 at 11:58 AM
ftsenews.co.uk logoAchaogen, Inc. (AKAO) Updated Price Targets - FTSE News (NASDAQ:AKAO)
www.ftsenews.co.uk - August 1 at 8:12 AM
investornewswire.com logoIs $12 Price Target Attainable For Achaogen, Inc. (NASDAQ:AKAO)? - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - July 24 at 8:10 AM
News IconStock Up Nicely This Week: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 23 at 3:24 PM
News IconEarnings Focus and Crowd Sourced Sentiment Review for Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 22 at 11:36 AM
fiscalstandard.com logoBroker Outlook For Achaogen, Inc. (AKAO) - Fiscal Standard (NASDAQ:AKAO)
www.fiscalstandard.com - July 21 at 8:58 PM
News IconAchaogen Inc Increases Again; Strong Momentum for Buyers - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 21 at 3:24 PM
News IconAchaogen Inc's Trend Up, Especially After Today's Strong Session - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 21 at 3:24 PM
News IconIs Achaogen Inc's Fuel Running Low? The Stock Just Declined Again - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 20 at 10:51 PM
News IconIncreased Stock Volatility Watch: Achaogen, Inc. (NASDAQ:AKAO) - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - July 20 at 10:51 PM
News IconShares Jumping Higher in Session: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 20 at 10:51 PM
equities.com logoAchaogen Inc. (AKAO) Jumps 9.63% on July 20 - Equities.com (NASDAQ:AKAO)
www.equities.com - July 20 at 10:51 PM
4-traders.com logoAchaogen Inc : LifeSci Capital Initiates Coverage of Achaogen (NASDAQ:AKAO)
www.4-traders.com - July 20 at 4:29 PM
News IconAchaogen Incorporated (NASDAQ:AKAO) Sellers Increased By 30.9% Their Shorts - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 19 at 8:51 PM
finance.yahoo.com logoLifeSci Capital Initiates Coverage of Achaogen (NASDAQ:AKAO)
finance.yahoo.com - July 19 at 1:45 PM
News IconInvestor Watch: Volatility Recap on Shares of: Achaogen, Inc. (NASDAQ:AKAO) - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - July 18 at 3:27 PM
finance.yahoo.com logoCerulean Pharma (CERU) Worth a Look: Stock Gains 9.1% (NASDAQ:AKAO)
finance.yahoo.com - July 18 at 8:45 AM
investornewswire.com logoStrong Sell Calls For Achaogen, Inc. (NASDAQ:AKAO) At 0 - Investor Newswire (NASDAQ:AKAO)
www.investornewswire.com - July 17 at 8:10 AM
News IconAchaogen Incorporated (NASDAQ:AKAO) Sellers Increased By 44.43% Their Shorts - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 16 at 3:24 PM
ftsenews.co.uk logoNew Broker Ratings For Achaogen, Inc. (AKAO) - FTSE News (NASDAQ:AKAO)
www.ftsenews.co.uk - July 15 at 7:41 PM
News IconShares Experiencing a Downtrend: Achaogen, Inc. (NASDAQ:AKAO) - TGP (NASDAQ:AKAO)
telanaganapress.com - July 15 at 7:41 PM
News IconIncreased Volatility Noted on Shares of: Achaogen, Inc. (NASDAQ:AKAO) - Engelwood Daily (NASDAQ:AKAO)
www.engelwooddaily.com - July 15 at 2:00 PM
publicnow.com logoAchaogen to Host Key Opinion Leader Meeting on Multi-Drug Resistant Infections on July 19, 2016 in New York (NASDAQ:AKAO)
www.publicnow.com - July 15 at 8:28 AM
finance.yahoo.com logoFoamix Pharmaceuticals (FOMX) Jumps: Stock Rises 7.1% (NASDAQ:AKAO)
finance.yahoo.com - July 15 at 8:25 AM
News IconInstitutional Investor Sentiment About Achaogen Inc (NASDAQ:AKAO) Increased - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 12 at 3:28 PM
News IconTrading Performance and Target Watch for Achaogen, Inc. (NASDAQ:AKAO) - Press Telegraph (NASDAQ:AKAO)
presstelegraph.com - July 12 at 8:32 AM
News IconWill Achaogen Inc Short Squeeze Soon? The Stock Formed a Bearish Double Bottom Pattern - Consumer Eagle (NASDAQ:AKAO)
www.consumereagle.com - July 11 at 8:29 PM

Social

Achaogen (NASDAQ:AKAO) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff